Alterity Therapeutics Files 6-K with ASX Price Query Response
Ticker: PRNAF · Form: 6-K · Filed: Jul 14, 2025 · CIK: 1131343
| Field | Detail |
|---|---|
| Company | Alterity Therapeutics Ltd (PRNAF) |
| Form Type | 6-K |
| Filed Date | Jul 14, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-K, regulatory-update
Related Tickers: ATHE
TL;DR
ALTERITY THERAPEUTICS LTD (ATHE) filed a 6-K with ASX price query response, check filings for details.
AI Summary
Alterity Therapeutics Ltd. filed a Form 6-K on July 14, 2025, incorporating by reference into several of its existing SEC registration statements. The filing includes Exhibit 99.1, which is a response to an ASX Price Query.
Why It Matters
This filing provides an update to investors regarding a query from the Australian Securities Exchange, potentially impacting the company's stock performance.
Risk Assessment
Risk Level: low — The filing is a routine report of foreign private issuer and incorporates previous filings, with no new material financial information or significant operational changes disclosed.
Key Players & Entities
- Alterity Therapeutics Ltd. (company) — Registrant
- ASX (company) — Australian Securities Exchange
- Form S-8 (document) — Registration Statement
- Form F-3 (document) — Registration Statement
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K is filed by Alterity Therapeutics Limited as a Report of Foreign Private Issuer and is being incorporated by reference into several of its existing SEC registration statements.
What specific exhibit is included with this filing?
The filing includes Exhibit 99.1, which is a Response to an ASX Price Query.
Which SEC registration statements does this 6-K filing incorporate by reference?
This Form 6-K is incorporated by reference into Alterity Therapeutics' Registration Statements on Form S-8 (Files No. 333-251073, 333-248980, and 333-228671) and Form F-3 (Files No. 333-274816, 333-251647, 333-231417, and 333-250076).
What is the principal executive office address of Alterity Therapeutics Limited?
The principal executive office is located at Level 14, 350 Collins Street, Melbourne, Victoria 3000, Australia.
Does Alterity Therapeutics file annual reports under Form 20-F or Form 40-F?
Alterity Therapeutics indicates it files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 14, 2025 regarding ALTERITY THERAPEUTICS LTD (PRNAF).